A Croatian scientist receives 1.5 million euros for research on tumours
JutarnjiLife, among other media from Croatia and Bosnia Herzegovina, has dedicated a space to Fran Supek, on the occasion of his receiving a Starting Grant from the European Research Council (ERC).
With this award, the ERC allows high-level scientists such as Supek to work long-term, “leading to important discoveries”. In this case, the research will focus on the genomes of hypermutated tumours.
Link to JutarnjiLife (Croatia)
Link to ZIMO (Croatia)
Link to Front Slobode (Bosnia Herzegovina)
Link to Hrvatska matica iseljenika (Croatia)
Related content
News
Modesto Orozco’s lab has published a paper in Chemical Communications about a therapeutic tool to prevent treatment resistance in breast cancer.
The tool has been tested in tumour cells in vitro and will now need to be tested in animal models before moving on to the development of a valid treatment for patients.
Muy Interesante, El Punt AVui, Diario Médico, Laboratory Journal and Federfarma, among other national and international media, have published articles about the research led by Núria López-Bigas, ICREA researcher at IRB Barcelona and that explains the origin of the mysterious periodicity in the genome.
Link to Muy Interesante
IRB Barcelona has been awarded two ERC PoC grants to optimise and validate tools with potential clinical applications.
Angel R. Nebreda’s project seeks to develop treatments to reduce the cardiotoxicity caused by chemotherapy.
Eduard Batlle’s project will build a biobank of mouse tumour organoids with the aim to contribute to the treatment of patients with advanced colon cancer.
